gms | German Medical Science

Kongress Medizin und Gesellschaft 2007

17. bis 21.09.2007, Augsburg

Markov Models and Discrete-Event-Simulation. A comparison of two powerful modelling techniques for economic evaluation

Meeting Abstract

Suche in Medline nach

  • Beate Jahn - Department für medizinische Statistik Informatik und Gesundheitsökonomie, Innsbruck
  • Engelbert Theurl - Department of Public Finance; Leopold-Franzens-University, Innsbruck
  • Karl-Peter Pfeiffer - A comparison of two powerful modelling techniques for economic evaluation, Innsbruck

Kongress Medizin und Gesellschaft 2007. Augsburg, 17.-21.09.2007. Düsseldorf: German Medical Science GMS Publishing House; 2007. Doc07gmds177

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/gmds2007/07gmds177.shtml

Veröffentlicht: 6. September 2007

© 2007 Jahn et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objectives: Markov models are applied to a great extend to evaluate the cost-effectiveness of competing health technologies. Recently Discrete-Event-Simulation (DES) has attract attention because of its flexibility to represent realistic clinical settings and treatment processes. This paper provides an overview of the main differences of these two modelling techniques and highlights situations where these alternatives are most appropriate.

Methods: Both modelling methods are illustrated on a real world example. The following discussion will be motivated by our own modelling experiences. A review of the leading methodological publications and recent applied studies will be presented. The focus will be a detailed discussion of major modelling issues (patient history, interactions of individuals, constrained resources).

Discussion: Markov models have the potential to describe the patient pathway over extended time horizons and to incorporate risks that are ongoing over time. These pathways are described by mutually exclusive states which represent clinically or economic events. The memoryless property of the stochastic process implies that the transition from the current state is independent from previously passed states. The individuals are assumed to be independent. These characteristics can lead to difficulties which can be overcome by DES. DES is widely used to model complex production lines and other service systems. However, it is fairly uncommon in health economics and strength and weaknesses are rarely discussed. Modellers and decision makers still face a lack of guidance for the selection of the appropriate approach.

Conclusion: The detailed discussion provides guidance for choosing an appropriate model, based on requirements and modelling effort. Therefore, it supports the improvement of decision analytic models. As a consequence it helps to increase the acceptance and the impact of these models on decision making.